Lupus & Connective Tissue Diseases
Conference Coverage
Rituximab tops azathioprine for relapsing ANCA-associated vasculitis remission maintenance
ATLANTA – The RITAZAREM trial results provide evidence that rituximab provides superior maintenance of remission in patients with relapsing...
Conference Coverage
Novel antibody looks promising in lupus nephritis
WASHINGTON – “We hypothesized that if we could deplete B cells more efficiently and completely, we would achieve better results.”
Conference Coverage
Heavy metals linked with autoimmune liver disease
BOSTON – Exposure to heavy metals from natural and man-made sources may contribute to development of autoimmune liver disease.
Conference Coverage
Apremilast for Behçet’s oral ulcers: Benefits maintained at 64 weeks
MADRID – Reassuring results of a long-term extension of the phase 3 RELIEF trial.
Conference Coverage
Weekly tocilizumab provides durable benefits for giant cell arteritis patients
ATLANTA – Tocilizumab’s effects in GCA patients proved durable in nearly half of the patients treated weekly during the GiACTA trial and its 2-...
Conference Coverage
CVD risk in black SLE patients 18 times higher than in whites
ATLANTA – “This study [identifies] a population that needs more attention, more targeted CVD prevention,” presenter Dr. Shivani Garg said.
Guidelines
EULAR releases recommendations for management of Sjögren’s syndrome
The recommendations are meant to “synthesize current thinking” on the management of the disease but are limited by a lack of high-quality evidence...
From the Journals
New screening test validated for cognitive impairment in lupus
The Automated Neuropsychological Assessment Metrics could be used to screen for cognitive impairment in adults with lupus.
From the Journals
Imaging reveals different clinico-pathologic patterns in Takayasu’s, giant cell arteritis
“Reliance on the presence of clinical symptoms may not be sensitive to detect vascular pathology within an acceptable window to prevent or...
Conference Coverage
Macitentan produces similar results in PAH-SSc and IPAH/HPAH
NEW ORLEANS – Rates of discontinuation, adverse events, and survival were similar in patients with PAH-SSc and those with IPAH or HPAH.
Conference Coverage
Many children who present to headache clinics have joint hypermobility
CHARLOTTE, N.C. – Joint hypermobility is associated with a high likelihood of severe headache disability among...